or
forgot password
  • cancer clinical trials in vermont

  • Iressa Expanded Access Program (EAP)
    Research Site
    Bennington, Vermont
    Carcinoma, Non-small-cell Lung, Metastases, Neoplasm
    A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
    University Of Vermont
    Burlington,, Vermont 05403
    Prostate Cancer
    Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
    University Of Vermont
    Burlington,, Vermont 05403
    Prostatic Neoplasms
    Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Vermont Cancer Center

    Trial Locations
    Vermont Cancer Center
    Green Mountain Oncology Group
    Veterans Affairs Medical Center - White River Junction
    Lung Cancer
    Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer
    Veterans Affairs Medical Center - White River Junction
    White River Junction, Vermont 05009
    Kidney Cancer
    CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer
    Pfizer Investigational Site
    Burlington, Vermont 05401-3456
    Carcinoma, Breast
    Genetic Study of Young Patients With Colorectal Cancer
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Colorectal Cancer
    Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Breast Cancer
    Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Head and Neck Cancer
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    Vermont Cancer Center at University of Vermont

    Trial Locations
    Vermont Cancer Center at University of Vermont
    Green Mountain Oncology Group
    Carcinoma of Unknown Primary
    Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
    Vermont Cancer Center at University of Vermont

    Trial Locations
    Vermont Cancer Center at University of Vermont
    Green Mountain Oncology Group
    Veterans Affairs Medical Center - White River Junction
    Colorectal Cancer, Diarrhea, Neutropenia
    Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Leukemia, Lymphoma
    Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Prostate Cancer
    Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Leukemia, Lymphoma
    Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    Vermont Cancer Center at University of Vermont

    Trial Locations
    Vermont Cancer Center at University of Vermont
    Green Mountain Oncology Group
    Veterans Affairs Medical Center - White River Junction
    Prostate Cancer
    PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Malignant Mesothelioma
    Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Cervical Cancer
    Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Leukemia
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Southwestern Vermont Health Care
    Bennington, Vermont 05201
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    Southwestern Vermont Health Care
    Bennington, Vermont 05201
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
    Mountainview Medical

    Trial Locations
    Mountainview Medical
    Fletcher Allen Health Care - University Health Center Campus
    Lymphoma
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Metastatic Cancer, Sarcoma
    Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Lymphoproliferative Disorder
    Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
    University Of Vermont
    Burlington,, Vermont 05403
    Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma, Peripheral Primitive Neuroectodermal Tumor
    Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Lung Cancer
    Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    University Of Vermont
    Burlington,, Vermont 05403
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Southwestern Vermont Regional Cancer Center

    Trial Locations
    Southwestern Vermont Regional Cancer Center
    Green Mountain Oncology Group
    Pancreatic Cancer
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    Fletcher Allen Health Care - Medical Center Hospital of Vermont Campus
    Burlington, Vermont 05401
    Endometrial Cancer
    Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma
    Mountainview Medical

    Trial Locations
    Mountainview Medical
    Fletcher Allen Health Care - University Health Center Campus
    Lymphoma
    GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
    Southwestern Oncology Research Department
    Bennington, Vermont 05201
    Prostate Cancer
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Rutland Regional Medical Center
    Rutland, Vermont 05701
    Lung Cancer, Non-small-cell Lung Carcinoma
    Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
    University of Vermont/Fletcher Allen Healthcare
    Burlington, Vermont 05401
    Glioblastoma Multiforme
    Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Colchester, Vermont 05446
    Non Small Cell Lung Cancer
    Trial of rPA-102 Vaccine in Healthy Adult Volunteers
    University of Vermont College of Medicine, Vermont Vaccine Evaluation Center
    Burlington, Vermont 05405
    Anthrax
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Brain and Central Nervous System Tumors
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Burlington, Vermont 05401-3456
    Colorectal Neoplasms
    Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
    GSK Investigational Site
    South Burlington, Vermont 05403
    Nausea and Vomiting, Chemotherapy-Induced, Chemotherapy-Induced Nausea and Vomiting